GILEAD SCIENCES DL-,001 revenue breakdown overview

GILEAD SCIENCES DL-,001 revenue for the last year amounted to 24.57 B EUR, the most of which — 24.57 B EUR — came from its highest performing source at the moment, Innovative Medicines, the year earlier bringing 25.49 B EUR. The greatest contribution to the revenue figure was made by United States — last year it brought GILEAD SCIENCES DL-,001 17.61 B EUR, and the year before that — 17.64 B EUR.